Detalhe da pesquisa
1.
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes.
J Allergy Clin Immunol
; 153(1): 349-353.e4, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633651
2.
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10399): 373-385, 2023 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311468
3.
Histological characterization of liver involvement in systemic mastocytosis.
Liver Int
; 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554045
4.
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study.
Am J Hematol
; 99(6): 1095-1102, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581211
5.
The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high-risk clonal cytopenia of unknown significance.
Genes Chromosomes Cancer
; 62(3): 139-151, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36412977
6.
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
Br J Haematol
; 198(3): 535-544, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438802
7.
Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies (GFM).
Transfusion
; 62(5): 961-973, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452143
8.
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study.
Clin Exp Rheumatol
; 40(7): 1336-1342, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579092
9.
Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase.
Br J Clin Pharmacol
; 86(5): 991-998, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31912911
10.
Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des Myélodysplasies.
Br J Haematol
; 182(6): 843-850, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30004110
11.
Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated Donors.
Biol Blood Marrow Transplant
; 21(5): 860-5, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25617807
12.
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study.
Lancet Haematol
; 10(7): e521-e529, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37245522
13.
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases.
Clin Exp Med
; 23(3): 803-813, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953763
14.
Efficient in vitro myogenic reprogramming of human primary mesenchymal stem cells and endothelial cells by Myf5.
Biol Cell
; 103(11): 531-42, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21810080
15.
Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study.
Leuk Lymphoma
; 63(6): 1398-1406, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35634787
16.
Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms - results of the EUROPE trial by EMSCO.
Leukemia
; 36(10): 2519-2527, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071100
17.
Impact of Mutational Status and Prognostic Factors on Survival in Chronic Myelomonocytic Leukemia With Systemic Inflammation and Autoimmune Disorders.
Hemasphere
; 7(3): e847, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36844177
18.
First clinical description of a pedigree with complete NAF1 deletion.
Leuk Lymphoma
; 64(2): 487-490, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36416722
19.
Looking for somatic mutations in UBA1 in patients with chronic myelomonocytic leukemia associated with systemic inflammation and autoimmune diseases.
Leuk Lymphoma
; 63(1): 250-252, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34474632
20.
A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML.
Leukemia
; 36(11): 2739-2742, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104395